Teva-Everolimus 5 mg (Everolimus TABLET) 5 MG

Teva-Everolimus 5 mg tablets are an oral medication used to manage certain medical conditions. This prescription drug is manufactured by Teva Canada Limited and is designed for oral administration.

Strength

5 MG

Manufacturer / TM Owner

TEVA CANADA LIMITED

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Everolimus is primarily used to manage conditions related to organ transplantation and certain types of cancer. It works by suppressing the immune system to prevent organ rejection or by targeting specific proteins in cancer cells. Patients often wonder, 'What is Everolimus used for?' and it is typically prescribed for these specific therapeutic purposes.

Side Effects

Common effects of Everolimus may include fatigue, nausea, and mouth sores. Some individuals might experience changes in appetite or mild digestive issues. These effects can vary depending on the individual and the specific condition being treated.

Precautions & Warnings

Everolimus should be handled with care and stored as directed. It is important to follow the advice of a healthcare provider regarding administration and to be aware of potential interactions with other medications. Always consult a healthcare professional before starting or stopping any medication.

Avoid Interactions

Everolimus may interact with certain medications, including those that affect the liver's ability to metabolize drugs. It is advisable to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol and other substances may also affect how Everolimus works in the body.

Frequently Asked Questions

Everolimus is used to manage conditions related to organ transplantation and certain types of cancer.

Everolimus is typically taken orally, as directed by a healthcare provider.

Common side effects may include fatigue, nausea, and mouth sores.

Everolimus may interact with other medications, so it is important to consult a healthcare provider before combining it with other drugs.

Precautions include following the healthcare provider's instructions and being aware of potential interactions with other medications.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.